Francesco Costa
Associate Professor of Practice

Biography
Francesco Costa is an Associate Professor of Practice of Government, Health & Not for Profit at SDA Bocconi School of Management. His collaboration with SDA Bocconi began in 2012, initially focusing primarily on the Drug Observatory of CERGAS (Center for Research on the Management of Healthcare and Social Services). Over time, he expanded his research activities to other thematic areas related to economic evaluations in healthcare, Health Technology Assessment, and Market Access.
Francesco has directed numerous courses for employees of pharmaceutical and medical technology companies, coordinating several sponsored training programs for doctors, pharmacists, and other healthcare professionals. Since 2018, he has been directing various editions of managerial training courses dedicated to drug access. Additionally, he teaches the Pharmaceutical Policy course within the Master in Management for Health (MiMS) at SDA Bocconi. From 2023, he holds the role of Coordinator of the Drug Observatory.
His current research activities focus on three main themes: 1) economic evaluations of healthcare technologies (cost-effectiveness analysis, cost-utility analysis, and budget impact analysis); 2) analysis of the pharmaceutical and medical device market in terms of performance, innovation, and response to public policies; 3) Market and Patient Access. He has published several articles in national and international refereed journals and authored chapters in various editions of the OASI Report (Observatory on Companies and the Italian Healthcare System), including the chapter analyzing healthcare spending, the main Italian publication on the healthcare system. Francesco is also the author of several articles published in "Il Sole 24 Ore Sanità" and a book on the organization and management of clinical trials. Additionally, he authored a chapter on the main drug policies in the book titled "L'Osservatorio del farmaco 2018".
He participates as an expert in advisory boards for companies in the pharmaceutical and medical device sector. Before starting his career at SDA Bocconi, he worked at two major multinational pharmaceutical companies in the areas of Market Access and New Business Development. Francesco earned a second-level master's degree in Management for Health at SDA Bocconi and a Ph.D. in Morphological Sciences at Università degli Studi di Milano. He previously graduated from Università degli Studi di Milano in Medical Biotechnology.
Recent Publications
- 2025
Politiche del farmaco: un approfondimento sull’innovatività terapeutica
ARMENI, P., L. CAVALLARO, F. COSTA, M. OTTO, "Politiche del farmaco: un approfondimento sull’innovatività terapeutica" in Rapporto OASI 2025., CERGAS (Ed.), Egea, chap. 8, 2025 - 2024
Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy
ROGNONI, C., D. LORUSSO, F. COSTA, P. ARMENI, "Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy", Advances in Therapy, 2024, vol. 41, no. 4, pp. 1385-1400 - 2024
Elicitation of societal preferences for chronic lymphocytic leukemia’s treatments: a discrete choice experiment
BORSOI, L., F. COSTA, C. MILANO, G. SEGANTIN, P. GHIA, P. ARMENI, "Elicitation of societal preferences for chronic lymphocytic leukemia’s treatments: a discrete choice experiment", Leukemia & Lymphoma, 2024, vol. 65, no. 11, pp. 1565-1575 - 2024
Politiche del farmaco: approfondimento sul Value Framework per i farmaci
ARMENI, P., L. CAVALLARO, F. COSTA, F. MALANDRINI, M. OTTO, "Politiche del farmaco: approfondimento sul Value Framework per i farmaci" in Rapporto OASI 2024., CERGAS (Ed.), Egea, chap. 8, pp. 333-362, 2024 - 2024
La copertura vaccinale nelle regioni italiane. Un’analisi dell’eterogeneità
ARMENI, P., L. CAVALLARO, F. COSTA, C. ROGNONI, R. TARRICONE, "La copertura vaccinale nelle regioni italiane. Un’analisi dell’eterogeneità" in Rapporto OASI 2024., CERGAS (Ed.), Egea, chap. 15, pp. 521-552, 2024 - 2023
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy
ROGNONI, C., C. FALIVENA, F. COSTA, P. ARMENI, "Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy", PharmacoEconomics, 2023, vol. 41, pp. 209–225 - 2023
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
TARANTOLA, A., M. OTTO, P. ARMENI, F. COSTA, F. MALANDRINI, C. JOMMI, "Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case", Journal of Pharmaceutical Policy and Practice, 2023, vol. 16, no. 1, pp. 67 - 2023
Economic impact of a more extensive use of FENO testing on the Italian population with asthma
ROGNONI, C., C. MILANO, E. HEFFLER, M. BONINI, L. BRUSSINO, G. E. CARPAGNANO, F. L. M. RICCIARDOLO, F. COSTA, P. ARMENI, "Economic impact of a more extensive use of FENO testing on the Italian population with asthma", Respiratory Research, 2023, vol. 24, pp. 147 - 2023
Pharmaceutical pricing and managed entry agreements: an exploratory study on future perspectives in Europe
JOMMI, C., A. BERTOLANI, P. ARMENI, F. COSTA, M. OTTO, "Pharmaceutical pricing and managed entry agreements: an exploratory study on future perspectives in Europe", Health Policy and Technology, 2023, vol. 12, no. 2, pp. 100771 - 2023
Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention
ROGNONI, C., G. SEGANTIN, R. SCARSINI, M. VALGIMIGLI, F. LOIZZI, F. COSTA, P. ARMENI, "Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention", Expert Review of Pharmacoeconomics & Outcomes Research, 2023, vol. 23, no. 9, pp. 1101-1111
You have seen 10 out of 79 items

